Denis Chem Lab Ltd

Denis Chem Lab Limited, a manufacturer of parenteral products, submitted a certificate to the BSE Limited on October 7, 2026, confirming compliance with Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended September 30, 2026, as issued by MUFG Intime India Private Limited, its registrar and share transfer agent.

Denis Chem Lab Limited, a manufacturer of parenteral products, informed the BSE Limited that its trading window will be closed from October 1, 2026, until 48 hours after the declaration of the company’s unaudited financial results for the quarter ended September 30, 2026, in accordance with SEBI’s insider trading regulations.

Denis Chem Lab Limited announced that shareholders approved the re-appointment of Dr. Himanshu C. Patel as Managing Director for a period of three years, effective August 1, 2026, through a virtual Annual General Meeting on September 25, 2026. Dr. Patel, who holds DIN 00087114, was re-appointed in place of his expiring term on July 31, 2026, and is not debarred from holding the office, according to a filing with the BSE Limited.

Denis Chem Lab Limited announced that shareholders approved the re-appointment of Dr. Himanshu C. Patel as Managing Director for a period of three years, effective August 1, 2026, through a virtual Annual General Meeting on September 25, 2026. Dr. Patel, who holds DIN: 00087114, was re-appointed in place of his expiring term on July 31, 2026, and is not debarred from holding the office, according to a filing with the BSE Limited.

Denis Chem Lab Limited will hold a board meeting on August 13, 2026, to approve the unaudited financial results for the quarter ended June 30, 2026, as per Securities and Exchange Board of India regulations, and the trading window for designated persons will remain closed until 48 hours after the financial results are declared.

Denis Chem Lab Limited announced the reappointment of Dr. Himanshu C. Patel as Managing Director for a period of 3 years, effective August 1, 2026, subject to shareholder approval at the company's 45th Annual General Meeting. Dr. Patel, an industrialist with over 4 decades of experience in the medical and pharmaceutical field, holds a B.E., M.S., and Ph.D., and currently holds 2048137 equity shares in the company.

Denis Chem Lab Limited announced that its board has re-appointed Dr. Himanshu C. Patel as Managing Director for a three-year term effective August 1, 2026, pending shareholder approval at the company’s 45th Annual General Meeting. The board also appointed M/s. Kashyap R. Mehta & Partners as Secretarial Auditors for five years, commencing financial year 2026-27, also subject to shareholder approval. The company will hold its 45th AGM on September 25, 2026, via video conferencing, and has fixed September 18, 2026, as the record date for dividend eligibility.

Denis Chem Lab Limited announced that its board has re-appointed Dr. Himanshu C. Patel as Managing Director for a three-year term effective August 1, 2026, pending shareholder approval at the company’s 45th Annual General Meeting. The board also appointed M/s. Kashyap R. Mehta & Partners as Secretarial Auditors for five years, commencing financial year 2026-27, also subject to shareholder approval. The company will hold its 45th AGM on September 25, 2026, via video conferencing, and has fixed September 18, 2026, as the record date for dividend eligibility.

Denis Chem Lab Limited announced that its board has re-appointed Dr. Himanshu C. Patel as Managing Director for a three-year term effective August 1, 2026, pending shareholder approval at the company’s 45th Annual General Meeting. The board also appointed M/s. Kashyap R. Mehta & Partners as Secretarial Auditors for five years, commencing financial year 2026-27, also subject to shareholder approval. The company will hold its 45th AGM on September 25, 2026, via video conferencing, and has fixed September 18, 2026, as the record date for dividend eligibility.

Denis Chem Lab Limited announced its board has appointed M/s. Kashyap R. Mehta & Partners as Secretarial Auditors for five years starting financial year 2026-27, and re-appointed Dr. Himanshu C. Patel as Managing Director for three years, both appointments subject to shareholder approval at the company’s 45th Annual General Meeting on September 25, 2026. The company will hold its AGM via video conferencing or other audio-visual means, with a record date of September 18, 2026, for dividend eligibility.